In vitro activity of chlorhexidine and pentane-1,5-diol and their combination on Candida albicans, Staphylococcus aureus and Propionibacterium acnes

Acta Dermato-Venereologica

Volumn 89, Issue 5, 2009, Pages 514-515

  Karami, Nahid ^a   Alsterholm, Mikael ^a   Faergemann, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; PENTANE 1,5 DIOL; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GROWTH INHIBITION; LETTER; MICROBIAL GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS, LOCAL; CANDIDA ALBICANS; CHLORHEXIDINE; GLYCOLS; HANDWASHING; HUMANS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; SKIN; STAPHYLOCOCCUS AUREUS;

EID: 70350142596     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0706     Document Type: Letter

References (15)

1. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-179. (Pubitemid 29055958)
2. Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 2003; 16: 189-208. (Pubitemid 36519807)
3. Digison MB. A review of anti-septic agents for pre-operative skin preparation. Plast Surg Nurs 2007; 27: 185-189; quiz 190-191.
4. Faergemann J, Wahlstrand B, Hedner T, Johnsson J, Neubert RH, Nyström L, et al. Pentane-1,5-diol as a percutaneous absorption enhancer. Arch Dermatol Res 2005; 297: 261-265.
5. Faergemann J, Fredriksson T. The antimycotic activity in vitro of five diols. Sabouraudia 1980; 18: 287-293. (Pubitemid 11170736)
6. Sundberg JJ, Faergemann J. A comparison of pentane-1,5-diol to other diols for use in dermatology. Expert Opin Investig Drugs 2008; 17: 601-610. (Pubitemid 351578177)
7. Faergemann J, Hedner T, Larsson P. The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage? Acta Derm Venereol 2005; 85: 203-205.
8. Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol 2008; 158: 442-455.
9. Hube B. Infection-associated genes of Candida albicans. Future Microbiol 2006; 1: 209-218.
10. Lobos O, Padilla A, Padilla C. In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains. Arch Oral Biol 2009; 54: 230-234.
11. Nascimento AP, Tanomaru JM, Matoba-Junior F, Watanabe E, Tanomaru-Filho M, Ito IY. Maximum inhibitory dilution of mouthwashes containing chlorhexidine and polyhexamethylene biguanide against salivary Staphylococcus aureus. J Appl Oral Sci 2008; 16: 336-339.
12. Adams D, Quayum M, Worthington T, Lambert P, Elliott T. Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect 2005; 61: 287-290. (Pubitemid 43009073)
13. Grabsch EA, Mitchell DJ, Hooper J, Turnidge JD. In-use efficacy of a chlorhexidine in alcohol surgical rub: a comparative study. ANZ J Surg 2004; 74: 769-772. (Pubitemid 39318665)
14. Karpanen TJ, Worthington T, Hendry ER, Conway BR, Lambert PA. Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J Antimicrob Chemother 2008; 62: 1031-1036.
15. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TS, Lambert PA. Penetration of chlorhexidine into human skin. Antimicrob Agents Chemother 2008; 52: 3633-3636.